Tag archive for: price

For the second year the Agnes McLaren Association is organizing a medical prize worth €4,000! Applications are open to students at the Montpellier-Nîmes Faculty of Medicine who will defend their clinical thesis between September 2021 and March 2023. See below for registration details and the eligibility criteria for your thesis.

 

This award recognizes a doctoral dissertation in medicine focusing on the health of women and/or children in precarious or vulnerable situations and funds research based on that dissertation

TheAgnes McLaren Association, founded in 2018, works to preserve the memory ofAgnes McLaren, a Scottish woman and the first female doctor to graduate from the Faculty of Medicine in Montpellier in 1878. It is in honor of this physician, who dedicated her life to caring for the most disadvantaged women or those excluded from society, that the association wishes to award a medical prize for the first time.

To mark the Faculty’s 800th anniversary in 2020, the association established the Agnès McLaren Prize in Medicine. Every two years, this prize is awarded for a clinical thesis and a post-thesis project, focusing on the health of women in precarious or vulnerable situations or the health of children exposed to precariousness and/or vulnerable situations. It also funds a project based on this thesis. The Prize, in the amount of €4,000, will be awarded in June 2023 following a preliminary selection by a committee and review by a jury composed of healthcare professionals.

In the first edition, Justine Allouche won an award for her knowledge and expertise in cervical cancer screening.

In 2021, the award was won by Justine Allouche for her work assessing knowledge and practices regarding cervical cancer screening among women in prostitution in the Gard and Hérault departments. Justine was featured in an article in Midi Libre on that occasion!

 

 

Eligibility Criteria

To be eligible for this medical award, candidates must meet several eligibility criteria:

 

  • Open to our students

    Criterion 1: Be a student at the Montpellier-Nîmes School of Medicine

  • Year 2021-22-23

    Criterion 2: Defend your thesis between September 2021 and March 2023

  • Thesis topic

    Criterion 3: Support a dissertation whose topic addresses the health of the most disadvantaged or even marginalized women, or the health of children exposed to precariousness and/or situations of vulnerability

  • Post-doctoral project

    Criterion 4: Thesis leading to an operational project

What are the steps to enter the contest?

The second edition of the McLaren Medical Award will take place in five phases, as follows:

  • by March 15, 2023

  • Pre-selection phase

    Preliminary screening of the theses received by the preliminary screening committee. Five theses were shortlisted.

    April 15, 2023

  • May 15, 2023

    Selection Notice

    Notification of selection sent to the five shortlisted candidates.

  • Final selection phase

    Review of the five theses shortlisted by the jury. Candidates must submit their theses and post-thesis work by January 24, 2021.

    June 2023

  • Sept. 2023

    Award Ceremony

    Presentation of the Agnes McLaren Award at the official ceremony.

Award Rules Pre-Application Package Application Form

We hope many of you will enter this new contest! So get writing, and good luck on your theses!

 

 

On Thursday, January 27, 2022, Dr. Catherine Alix-Panabières received the prestigious Savchuk Prize at the 15th Oncology Biennial for her work on “liquid biopsies.” A look back at 23 years of research in the field of oncology.

A career focused on the development of liquid biopsy

Dr. Alix-Panabières, director of the Rare Human Circulating Cells (CCRH) laboratory at Montpellier University Hospital, has been dedicated to her research for 23 years. Coined by her in 2010 with her German collaborator, Professor Klaus Pantel of Hamburg, the term “liquid biopsy”—which complements tissue biopsy—refers to a blood test that is performed repeatedly during a patient’s treatment.

 

A non-invasive procedure

A liquid biopsy provides access to circulating cells or particles released by the primary tumor or metastases. The advantage? It allows for the repeated, non-invasive monitoring of tumors located in hard-to-reach areas. After the blood sample is collected, it provides information on the tumor’s progression and, consequently, the effectiveness of treatment.

His research focuses on three key areas:

  1. Understanding the biology of the tumor and its prognosis.
  2. Technology: Dr. Alix-Panabières is working on a patent for this new technique, which enables the detection of circulating tumor cells.
  3. A translational clinical study. Liquid biopsy allows treatment to be tailored to each patient’s stage of disease, particularly when initiating treatment.

We extend our heartfelt congratulations to Dr. Catherine Alix-Pananières on winning this award!